ESC Premium Access

Improvement in FFR predicts 2 years outcome after PCI. A FAME 2 Sub-Analysis.

Presentation

About the speaker

Doctor Stephane Fournier

University Hospital Center Vaudois (CHUV), Department of Cardiology, Lausanne (Switzerland)
4 presentations
0 follower

5 more presentations in this session

The Bivalirudin versus Heparin in non-ST and ST-segment elevation myocardial infarction in patients on modern antiplatelet therapy in SWEDEHEART

Speaker: Professor D. Erlinge (Lund, SE)

Thumbnail

Efficacy and Safety of a Pharmaco-Invasive Strategy versus Primary Angioplasty in ST-Elevation Myocardial Infarction: The EARLY-MYO Trial

Speaker: Doctor B. HE (Shanghai, CN)

Thumbnail

Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes - TROPICAL-ACS - Trial

Speaker: Professor D. Sibbing (Munich, DE)

Thumbnail

RE-DUAL PCI : Dual Antithrombotic Therapy with Dabigatran After Percutaneous Coronary Intervention in Patients with Atrial Fibrillation

Speaker: Professor C. Cannon (Boston, US)

Thumbnail

Have we reached the bottom line in mortality after Acute Myocardial Infarction? Changes over 20 years in patient characteristics, management, and 6-month outcomes in the FAST-MI programme: 1995-2015

Speaker: Professor N. Danchin (Paris, FR)

Thumbnail

Access the full session

Late-Breaking Science in PCI 2

Speakers: Doctor S. Fournier, Professor D. Erlinge, Doctor B. HE, Professor D. Sibbing, Professor C. Cannon...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk